IL-6 produced by type I IFN DC controls IFN-γ production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells

被引:27
作者
Detournay, O [1 ]
Mazouz, N [1 ]
Goldman, M [1 ]
Toungouz, M [1 ]
机构
[1] Erasme Univ Hosp, Dept Immunol Hematol Transfus, B-1070 Brussels, Belgium
关键词
dendritic cells; IFN-gamma; IL-6; regulatory T cells; type IIFN;
D O I
10.1016/j.humimm.2005.01.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The dendritic cell family is composed of different subsets differentially governing the immune response. Type I interferon (IFN) dendritic cells (DC) are endowed with the ability to trigger both Th1 and Th2 type responses. In view of the pivotal role of regulatory T cells in limiting the effectiveness of effector cells, we analyzed the interactions between these cells and type I IFN DC. DC were generated from monocytes in the presence of IFN-beta and interleukin (IL)-3 (DC13) or granulocyte macrophage-colony-stimulating factor and IL-4 (DCG4) and activated by poly(I:C). Despite the release of lower amounts of IL-12 after maturation, DC13 were able to induce a higher IFN-gamma production by T lymphocytes during the mixed leucocyte reaction (MLR) as compared with DCG4. mRNA analysis disclosed that DC13 overtranscribed the IL-6 gene and secreted high amounts of the protein. Neutralization of IL-6 revealed that this cytokine specifically contributed to the IFN-gamma release induced by DC13. Finally, depletion of CD25+ T cells before the MLR identified these cells as a target for IL-6. We conclude that DC13 are endowed with the property of regulating the suppressive effect of regulatory T cells through high IL-6 production. This novel mechanism of T cell control is relevant for the use of DC13 in vaccination strategies.
引用
收藏
页码:460 / 468
页数:9
相关论文
共 37 条
[31]   Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice [J].
Santini, SM ;
Lapenta, C ;
Logozzi, M ;
Parlato, S ;
Spada, M ;
Di Pucchio, T ;
Belardelli, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (10) :1777-1788
[32]   IFN-α and IL-12 induce IL-18 receptor gene expression in human NK and T cells [J].
Sareneva, T ;
Julkunen, I ;
Matikainen, S .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :1933-1938
[33]   Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use [J].
Spisek, R ;
Bretaudeau, L ;
Barbieux, I ;
Meflah, K ;
Gregoire, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (08) :417-427
[34]  
Steinbrink K, 1997, J IMMUNOL, V159, P4772
[35]   Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells [J].
Steinbrink, K ;
Jonuleit, H ;
Müller, G ;
Schuler, G ;
Knop, J ;
Enk, AH .
BLOOD, 1999, 93 (05) :1634-1642
[36]   Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia [J].
Trenado, A ;
Charlotte, F ;
Fisson, S ;
Yagello, M ;
Klatzmann, D ;
Salomon, BL ;
Cohen, AL .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (11) :1688-1696
[37]   Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells [J].
Yamazaki, S ;
Iyoda, T ;
Tarbell, K ;
Olson, K ;
Velinzon, K ;
Inaba, K ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (02) :235-247